{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T04:23:14Z","timestamp":1751430194908,"version":"3.41.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgical Clinics of North America"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.suc.2024.11.001","type":"journal-article","created":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T20:16:08Z","timestamp":1736194568000},"page":"375-383","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Primary Sclerosing Cholangitis and Inflammatory Bowel Disease"],"prefix":"10.1016","volume":"105","author":[{"given":"Jessica Colin","family":"Escobar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Navarez","family":"Pereyra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Ali","family":"Abbass","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.suc.2024.11.001_bib1","first-page":"124","article-title":"Primary sclerosing cholangitis and inflammatory bowel disease comorbidity: an update of the evidence","volume":"32","author":"Mertz","year":"2019","journal-title":"Ann Gastroenterol"},{"issue":"1","key":"10.1016\/j.suc.2024.11.001_bib2","doi-asserted-by":"crossref","first-page":"17","DOI":"10.5009\/gnl16510","article-title":"Inflammatory bowel disease and primary sclerosing cholangitis: a review of the phenotype and associated specific features","volume":"12","author":"Palmela","year":"2018","journal-title":"Gut Liver"},{"key":"10.1016\/j.suc.2024.11.001_bib3","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/MEG.0000000000000532","article-title":"Primary sclerosing cholangitis associated with inflammatory bowel disease: an update","volume":"28","author":"Rossi","year":"2016","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.suc.2024.11.001_bib4","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1080\/00365529850166284","article-title":"Incidence and prevalence of primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis in a Norwegian population","volume":"33","author":"Boberg","year":"1998","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.suc.2024.11.001_bib5","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1002\/hep.24247","article-title":"Incidence of primary sclerosing cholangitis: a systematic review and meta-analysis","volume":"53","author":"Molodecky","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.suc.2024.11.001_bib6","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.3748\/wjg.v21.i6.1956","article-title":"Distinctive inflammatory bowel disease phenotype in primary sclerosing cholangitis","volume":"21","author":"de Vries","year":"2015","journal-title":"World J Gastroenterol"},{"issue":"44","key":"10.1016\/j.suc.2024.11.001_bib7","doi-asserted-by":"crossref","first-page":"6213","DOI":"10.3748\/wjg.v28.i44.6213","article-title":"Role of intestinal flora in primary sclerosing cholangitis and its potential therapeutic value","volume":"28","author":"Li","year":"2022","journal-title":"World J Gastroenterol"},{"issue":"24","key":"10.1016\/j.suc.2024.11.001_bib8","doi-asserted-by":"crossref","first-page":"512","DOI":"10.21037\/atm.2016.12.43","article-title":"The \"gut microbiota\" hypothesis in primary sclerosing cholangitis","volume":"4","author":"Pontecorvi","year":"2016","journal-title":"Ann Transl Med"},{"issue":"41","key":"10.1016\/j.suc.2024.11.001_bib9","doi-asserted-by":"crossref","first-page":"5421","DOI":"10.3748\/wjg.v13.i41.5421","article-title":"Genetic epidemiology of primary sclerosing cholangitis","volume":"13","author":"Karlsen","year":"2007","journal-title":"World J Gastroenterol"},{"issue":"4","key":"10.1016\/j.suc.2024.11.001_bib10","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1136\/gutjnl-2019-318416","article-title":"Alterations of the bile microbiome in primary sclerosing cholangitis","volume":"69","author":"Liwinski","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.suc.2024.11.001_bib12","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1002\/ibd.22938","article-title":"Primary sclerosing cholangitis is associated with a distinct phenotype of inflammatory bowel disease","volume":"18","author":"Boonstra","year":"2012","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.suc.2024.11.001_bib13","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1007\/s00534-010-0319-8","article-title":"Clinical characteristics of inflammatory bowel disease associated with primary sclerosing cholangitis","volume":"18","author":"Sano","year":"2011","journal-title":"J\u00a0Hepatobiliary Pancreat Sci"},{"key":"10.1016\/j.suc.2024.11.001_bib14","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.1007\/s10620-013-2697-7","article-title":"The phenotypic expression of inflammatory bowel disease in patients with primary sclerosing cholangitis differs in the distribution of colitis","volume":"58","author":"Schaeffer","year":"2013","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.suc.2024.11.001_bib15","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1136\/gut.2010.235408","article-title":"Does the severity of primary sclerosing cholangitis influence the clinical course of associated ulcerative colitis?","volume":"60","author":"Marelli","year":"2011","journal-title":"Gut"},{"key":"10.1016\/j.suc.2024.11.001_bib16","series-title":"StatPearls","article-title":"Primary sclerosing cholangitis","author":"Rawla","year":"2023"},{"issue":"5","key":"10.1016\/j.suc.2024.11.001_bib17","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/ajg.2015.112","article-title":"ACG clinical guideline: primary sclerosing cholangitis","volume":"110","author":"Lindor","year":"2015","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.suc.2024.11.001_bib18","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/MEG.0000000000000576","article-title":"Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and inflammatory bowel disease: a meta-analysis of 16 observational studies","volume":"28","author":"Zheng","year":"2016","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.suc.2024.11.001_bib19","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1080\/00365520801977568","article-title":"Relationship between clinical parameters and the colitis-colorectal cancer interval in a cohort of patients with colorectal cancer in inflammatory bowel disease","volume":"44","author":"Brackmann","year":"2009","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.suc.2024.11.001_bib20","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1002\/ibd.20886","article-title":"More right-sided IBD-associated colorectal cancer in patients with primary sclerosing cholangitis","volume":"15","author":"Claessen","year":"2009","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.suc.2024.11.001_bib21","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1002\/hep.23294","article-title":"Diagnosis and management of primary sclerosing cholangitis","volume":"51","author":"Chapman","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.suc.2024.11.001_bib22","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jhep.2009.04.009","article-title":"EASL clinical practice guidelines: management of cholestatic liver diseases","volume":"51","year":"2009","journal-title":"J\u00a0Hepatol"},{"issue":"2","key":"10.1016\/j.suc.2024.11.001_bib23","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1093\/ecco-jcc\/jjy113","article-title":"ECCO-ESGAR guideline for diagnostic assessment in IBD Part 1: initial diagnosis, monitoring of known IBD, detection of complications","volume":"13","author":"Maaser","year":"2019","journal-title":"Journal of Crohn's and Colitis"},{"issue":"10139","key":"10.1016\/j.suc.2024.11.001_bib24","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1016\/S0140-6736(18)30300-3","article-title":"Primary sclerosing cholangitis","volume":"391","author":"Dyson","year":"2018","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.suc.2024.11.001_bib26","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1002\/hep.510290427","article-title":"Recurrence of primary sclerosing cholangitis following liver transplantation","volume":"29","author":"Graziadei","year":"1999","journal-title":"Hepatology"},{"issue":"12","key":"10.1016\/j.suc.2024.11.001_bib27","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1093\/ibd\/izz325","article-title":"Activity of inflammatory bowel disease after liver transplantation for primary sclerosing cholangitis predicts poorer clinical outcomes","volume":"26","author":"Peverelle","year":"2020","journal-title":"Inflamm Bowel Dis"},{"issue":"3","key":"10.1016\/j.suc.2024.11.001_bib28","doi-asserted-by":"crossref","first-page":"222","DOI":"10.3390\/jpm14030222","article-title":"Risk factors for recurrence of primary sclerosing cholangitis after liver transplantation: single-center data","volume":"14","author":"Catanzaro","year":"2024","journal-title":"J\u00a0Personalized Med"},{"issue":"6","key":"10.1016\/j.suc.2024.11.001_bib29","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1111\/apt.15148","article-title":"Systematic review with meta-analysis: risk factors for recurrent primary sclerosing cholangitis after liver transplantation","volume":"49","author":"Steenstraten","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"issue":"12","key":"10.1016\/j.suc.2024.11.001_bib30","article-title":"Inflammatory conditions play a role in recurrence of PSC after liver transplantation: an international multicentre study","volume":"4","author":"Visseren","year":"2022","journal-title":"JHEP Rep"},{"issue":"28","key":"10.1016\/j.suc.2024.11.001_bib31","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.3748\/wjg.v24.i28.3171","article-title":"Role of colectomy in preventing recurrent primary sclerosing cholangitis in liver transplant recipients","volume":"24","author":"Buchholz","year":"2018","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.suc.2024.11.001_bib32","doi-asserted-by":"crossref","DOI":"10.3389\/ti.2023.11729","article-title":"Liver transplantation for primary sclerosing cholangitis (PSC) with or without inflammatory bowel disease (IBD)-A European Society of Organ Transplantation (ESOT) consensus statement","volume":"36","author":"Carbone","year":"2023","journal-title":"Transpl Int"},{"key":"10.1016\/j.suc.2024.11.001_bib33","series-title":"StatPearls","article-title":"Primary sclerosing cholangitis","author":"Rawla","year":"2023"},{"issue":"5","key":"10.1016\/j.suc.2024.11.001_bib34","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/ajg.2015.112","article-title":"ACG clinical guideline: primary sclerosing cholangitis","volume":"110","author":"Lindor","year":"2015","journal-title":"Am J Gastroenterol"},{"issue":"8","key":"10.1016\/j.suc.2024.11.001_bib35","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1093\/ecco-jcc\/jjab025","article-title":"Systematic review and meta-analysis of outcomes after ileal pouch-anal anastomosis in primary sclerosing cholangitis and ulcerative colitis","volume":"15","author":"Barnes","year":"2021","journal-title":"Journal of Crohn's & colitis"},{"issue":"5","key":"10.1016\/j.suc.2024.11.001_bib36","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s00384-011-1140-9","article-title":"The clinical impact of primary sclerosing cholangitis in patients with an ileal pouch-anal anastomosis for ulcerative colitis","volume":"26","author":"Rahman","year":"2011","journal-title":"Int J Colorectal Dis"},{"issue":"7","key":"10.1016\/j.suc.2024.11.001_bib37","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.cgh.2016.11.036","article-title":"Risk of rectal cancer after colectomy for patients with ulcerative colitis: a national cohort study","volume":"15","author":"Abdalla","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"8","key":"10.1016\/j.suc.2024.11.001_bib38","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1093\/ecco-jcc\/jjx027","article-title":"Risk of rectal neoplasia after colectomy and ileorectal anastomosis for ulcerative colitis","volume":"11","author":"Uzzan","year":"2017","journal-title":"Journal of Crohn's & colitis"},{"issue":"12","key":"10.1016\/j.suc.2024.11.001_bib39","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1016\/j.cgh.2019.07.011","article-title":"AGA clinical practice update on surveillance for hepatobiliary cancers in patients with primary sclerosing cholangitis: expert review","volume":"17","author":"Bowlus","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.suc.2024.11.001_bib40","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.jhep.2022.05.011","article-title":"European association for the study of the liver (2022). EASL clinical practice guidelines on sclerosing cholangitis","volume":"77","year":"2022","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.suc.2024.11.001_bib41","unstructured":"Bleibel W, Chopra S, Curry MP. Portal hypertension in adults. In: Post TW, ed. UpToDate. UpToDate; 2024. Accessed August 1, 2024. Available at: https:\/\/www.uptodate.com\/contents\/portal-hypertension-in-adults?search=portal%20hypertension%20treatment&source=search_result&selectedTitle=1%7E150&usage_type=default&display_rank=1#H72827649."},{"key":"10.1016\/j.suc.2024.11.001_bib42","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jhep.2008.08.013","article-title":"High lifetime risk of cancer in primary sclerosing cholangitis","volume":"50","author":"Claessen","year":"2009","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.suc.2024.11.001_bib43","first-page":"1404","article-title":"Primary sclerosing cholangitis and ulcerative colitis: evidence for increased neoplastic potential","volume":"22","author":"Broom\u00e9","year":"1995","journal-title":"Hepatology"},{"key":"10.1016\/j.suc.2024.11.001_bib44","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1067\/mge.2002.125367","article-title":"Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis: a meta-analysis","volume":"56","author":"Soetikno","year":"2002","journal-title":"Gastrointest Endosc"}],"container-title":["Surgical Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039610924001567?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039610924001567?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T20:38:34Z","timestamp":1751402314000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039610924001567"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S0039610924001567"],"URL":"https:\/\/doi.org\/10.1016\/j.suc.2024.11.001","relation":{},"ISSN":["0039-6109"],"issn-type":[{"type":"print","value":"0039-6109"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Primary Sclerosing Cholangitis and Inflammatory Bowel Disease","name":"articletitle","label":"Article Title"},{"value":"Surgical Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.suc.2024.11.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}